These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38853490)

  • 1. Rehabilitation for Functional Dystonia: Cases and Review of the Literature.
    Gros P; Bhatt H; Gilmour GS; Lidstone SC
    Mov Disord Clin Pract; 2024 Jun; ():. PubMed ID: 38853490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Dystonia: Differentiation From Primary Dystonia and Multidisciplinary Treatments.
    Frucht L; Perez DL; Callahan J; MacLean J; Song PC; Sharma N; Stephen CD
    Front Neurol; 2020; 11():605262. PubMed ID: 33613415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective review.
    Ehrlich DJ; Frucht SJ
    J Clin Mov Disord; 2016; 3():15. PubMed ID: 31413859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonias: Clinical Recognition and the Role of Additional Diagnostic Testing.
    Stephen CD; Dy-Hollins M; Gusmao CM; Qahtani XA; Sharma N
    Semin Neurol; 2023 Feb; 43(1):17-34. PubMed ID: 36972613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiotherapy rehabilitation after total knee or hip replacement: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(8):1-91. PubMed ID: 23074477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
    Danchenko N; Johnston KM; Whalen J
    J Med Econ; 2022; 25(1):919-929. PubMed ID: 35730362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.
    Esper CD; Freeman A; Factor SA
    Parkinsonism Relat Disord; 2010 Aug; 16(7):438-41. PubMed ID: 20494607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is myasthenia gravis a contraindication for botulinum toxin?
    Ma Q; Ran H; Ou C; Liu X; Lu Y; Huang H; Yang W; Yu L; Chen P; Huang X; Qiu L; Lin Z; Huang Z; Liu W
    J Clin Neurosci; 2022 Jan; 95():44-47. PubMed ID: 34929650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tablet-based patient educational interventions in care and management of complex movement disorders.
    Hellmers N; Barkan S; Auerbach G; Hanineva A; Popa P; Sarva H; Henchcliffe C
    Disabil Rehabil Assist Technol; 2023 Jul; 18(5):627-634. PubMed ID: 33784918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Dystonia (Torticollis).
    Brin MF; Benabou R
    Curr Treat Options Neurol; 1999 Mar; 1(1):33-43. PubMed ID: 11096693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the pharmacotherapeutics for dystonia: advances over the past decade.
    Abu-Hadid O; Jimenez-Shahed J
    Expert Opin Pharmacother; 2022 Dec; 23(17):1927-1940. PubMed ID: 36394521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal task-specific lower extremity dystonia associated with intense repetitive exercise: a case series.
    Katz M; Byl NN; San Luciano M; Ostrem JL
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1033-8. PubMed ID: 23932354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory Laryngeal Dystonia: Characterization and Diagnosis of a Rare Neurogenic Disorder.
    Tierney WS; Bryson PC; Nelson R; Kaplan SE; Benninger MS; Milstein CF
    Laryngoscope; 2020 Dec; 130(12):2843-2846. PubMed ID: 32073668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
    Müller J; Wenning GK; Wissel J; Seppi K; Poewe W
    J Neurol; 2002 Mar; 249(3):300-4. PubMed ID: 11993530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.